Photo: Getty
It’spurrfect news for feline fanatics who also suffer from cat allergies.
“It is known that decreasing exposure of allergic humans to Fel d 1 has a significant benefit on symptoms and health. HypoPet’s innovative approach is to intervene ‘at the source’ i.e. lower allergenic Fel d 1 on the cat itself,” the Swiss company wrote.
The vaccine for felines that HypoPet has been working on induces anti‐Fel d 1 antibodies in the cat.
“These antibodies bind to Fel d 1 and thus have the ability to lower or neutralize its allergenic effect in humans,” HypoPet added.
The company recently revealed that four separate studies, involving 54 cats, have proven successful.
Hypo Pet’s Zurich-based research team found that the vaccine “successfully induced Fel d 1 binding antibodies in cats and that these antibodies neutralized the allergen.” These exciting results were published in theJournal of Allergy and Clinical Immunology.
It is important to note that if the HypoCat vaccine comes to market, it will be to treat individual felines. The vaccine will neutralize allergens in each treated cat; the vaccine will not prevent allergy suffers from having allergic reactions to all cats.
source: people.com
